Nonalcoholic fatty liver disease (NAFLD) is demonstrated to be closely related to the
disorder of gut microbiota and the intestinal mucosal barrier. Luteolin is a natural flavonoid …

Background Non-alcoholic fatty liver disease (NAFLD) is a common liver disease that may
progress into, in the absence of proper treatment, severe liver damage. While the optimal …

Background and Aims NASH is currently one of the most common causes of liver
transplantation and hepatocellular carcinoma. Thus far, there is still no effective …

Background and Aims NAFLD is a growing public health burden. However, the
pathogenesis of NAFLD has not yet been fully elucidated, and the importance of genetic …

Background Obesity and its comorbidities are associated with abnormal lipid metabolism
and gut microbiota dysbiosis. Bupleuri Radix is a medicinal plant used in traditional Chinese …

Non-alcoholic fatty liver disease (NAFLD) is a common metabolic disorder that causes
excess lipid accumulation in the liver and is the leading cause of end-stage liver disease …

Background Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty
liver disease (NAFLD) for which there is yet any standard pharmacotherapy. Traditional …

OBJECTIVE To investigate the effects of saikosaponin-d (SSd) on the proliferation of L02
cells induced by H 2 O 2 and the mechanism. METHODS ① L02 cells were pretreated with …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Its pathogenesis is closely related to insulin resistance, obesity, type 2 diabetes, and …

BACKGROUND Nonalcoholic fatty liver disease (NAFLD) affects more than one-quarter of
the global population. Due to the lack of approved chemical agents, many patients seek …